Back to search
FDAFDA · Food and drugs·Recall number D-0844-2022

alprazolam XR extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977, NDC 59762-0068-1.

Published May 11, 2022 · Recall initiated: April 28, 2022

Summary

FDA records drug Class II recall D-0844-2022, published May 11, 2022 and initiated April 28, 2022. Recalling firm: Viatris Inc; Status: Terminated; Reported quantity: 6,789 bottles; Lot: Lot # EH8348, exp. date August 2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: low out-of-specification dissolution test results observed.

What to do

Voluntary: Firm initiated · Letter

Get an email if ALPRAZOLAM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ALPRAZOLAM
Manufacturer
Viatris Inc
Distributor
Product was distributed nationwide in the USA
Lot
Lot # EH8348, exp. date August 2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was alprazolam XR extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977, NDC 59762-0068-1. recalled?

Yes. FDA published recall D-0844-2022 on May 11, 2022. Reported hazard: Failed Dissolution Specifications: low out-of-specification dissolution test results observed.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ALPRAZOLAM.